Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma with Adverse Karyotypes
NCT01745640Phase 2Completed
- Sponsor
- CHU de Lille
- Start
- Jan 2012
- Primary completion
- Dec 2015
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in multiple myeloma (MM), sponsored by CHU de Lille. Started Jan 2012; status: completed.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01745640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01745640.